Group-based Psychoeducation for Relatives of Patients With Bipolar Disorder, a Randomized Controlled Trial
R-Bipolar
1 other identifier
interventional
206
1 country
1
Brief Summary
Relatives of patients with bipolar disorder (BD) often experience emotional burden with stress, and depressive symptoms that again increases the likelihood of destabilization and relapses in the patient. The effects of group-based psychoeducation have not been investigated in large-scale real-world settings. The investigators are currently conducting a large-scale real-world randomized controlled parallel group trial (RCT) to test whether group-based psychoeducation for relatives to patients with BD improves mood instability and other critical outcomes in relatives and the corresponding patients with BD. The trial is designed as a two-arm, parallel group randomized trial with a balanced randomization 1:1 to either group-based psychoeducation or a waiting list for approximately 4 months and subsequent group-based psychoeducation. the investigators plan to include 200 relatives. The group sizes for psychoeducation is between 20-40 relatives.The primary outcome measure is mood instability calculated based on daily smartphone-based mood self-assessment. Other relevant outcomes are measured, including patients' reported outcomes, assessing self-assessed burden, self-efficacy, and knowledge about BD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 7, 2022
CompletedFirst Submitted
Initial submission to the registry
November 29, 2023
CompletedFirst Posted
Study publicly available on registry
December 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedSeptember 26, 2025
June 1, 2025
2.2 years
November 29, 2023
September 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in mood instability in the relatives
Mood instability is calculated from daily self-reported mood registration in the app Monsenso. Participating relatives score their daily mood on a 9-point scale from 0-8 where 8 is 'in a brilliant mood' and 0 is 'really sad' The participant rate daily in the Monsenso app during the time the participate in the study (4-8 months depending on which group they are randomly allocated to). For each participant, a mood instability measure will be estimated for each day and aggregated by applying the root mean square successive difference (rMSSD) method.
daily in 4-8 months.
Change in mood instability in the corresponding patients
Mood instability is calculated from daily self-reported mood registration via the app Monsenso. The patients score their daily mood on a scale from -3 to +3, where -3 is the worst and +3 is the best mood. Patients' data from the Monsenso app is collected from a parallel RCT, in the time frame in which the relatives are in the study.
daily in 4-8 months.
Secondary Outcomes (15)
Self-reported daily registrations in the Monsenso app on the following topics: daily activity level, sleep, mixed moods, anxiety, irritability, cognition, stress, alchohol consumption, patient support and level of burden from being a caregiver,
daily 4-8 months.
Self-rated caregiver burden
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
Self-rated expressed emotions
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
Self-rated quality of life
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
Self-rated carer self-efficacy
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
- +10 more secondary outcomes
Other Outcomes (1)
Change in automatically smarthone-generated data
4-8 months
Study Arms (2)
Psychoeducation
ACTIVE COMPARATORParticipants randomized to this arm are offered group-based psychoeducation shortly thereafter.
Waiting list
PLACEBO COMPARATORParticipants randomized to this arm are placed on a waiting list for approximately 4 months and then offered group-based psychoeducation thereafter.
Interventions
Group-based psychoeducation for relatives. Group size: 20-40 relatives. Duration of intervention: six sessions, each two hours long with a 15 minutes break, over a period of 6-10 weeks. The sessions are held by experienced clinicians from the Copenhagen Affective Disorder Clinic, one chief physician and one nurse. Each session focuses on a specific topic, which the clinicians present and discuss using a presentation viewer. The sessions are interactive, and the participants are encouraged to ask questions during the presentations. During each session the participants will have some discussions in smaller groups to reflect on a topics and issues raised during the session.
Eligibility Criteria
You may qualify if:
- Relatives of patients with Bipolar Disorder who are affiliated with the Copenhagen Affective Disorder Clinic.
You may not qualify if:
- Insufficient Danish language.
- Age below 18 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Copenhagen Affective Disorder Clinic
Copenhagen, 2000, Denmark
Related Publications (2)
Stokholm JR, Waldemar AK, Kessing LV. Becoming diplomats with boundaries - a thematic analysis of relatives' experiences with group-based psychoeducation about bipolar disorder. BMC Psychiatry. 2025 Sep 1;25(1):843. doi: 10.1186/s12888-025-07219-y.
PMID: 40890647DERIVEDStokholm JR, Vinberg M, Faurholt-Jepsen M, Kessing LV. Study protocol: group-based psychoeducation for relatives of patients with bipolar disorder-a large scale real-world randomized controlled parallel group trial, the R-bipolar RCT. Trials. 2024 May 23;25(1):342. doi: 10.1186/s13063-024-08172-z.
PMID: 38783322DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars V Kessing, professor
Copenhagen Psychiatric Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
November 29, 2023
First Posted
December 19, 2023
Study Start
April 7, 2022
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
September 26, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share